GlobeNewswire
Bundled Pay Management Software Analysis Report 2026-2035: A $7.25+ Billion Market by 2030 with UnitedHealth, McKesson, Oracle, Tata Consultancy Services Leading
📈
AI Sentiment
Highly Positive
9/10
- Home
- MCK
as of 02-20-2026 4:00pm EST
$947.48
+$10.34
+1.10%
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
| Founded: | 1833 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 101.9B | IPO Year: | 1995 |
| Target Price: | $930.23 | AVG Volume (30 days): | 794.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 24.73 | EPS Growth: | 14.87 |
| 52 Week Low/High: | $598.58 - $971.93 | Next Earning Date: | 05-06-2026 |
| Revenue: | $112,084,000,000 | Revenue Growth: | 3.11% |
| Revenue Growth (this year): | 14.97% | Revenue Growth (next year): | 8.17% |
| P/E Ratio: | 37.91 | Index: | |
| Free Cash Flow: | 5.5B | FCF Growth: | +418.05% |
AI-Powered MCK Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 73.62%
73.62%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of McKesson Corporation (MCK)
Smith LeAnn B
Sell
EVP & Chief HR Officer
MCK Feb 17, 2026
Avg Cost/Share
$945.00
Shares
190
Total Value
$179,550.00
Owned After
2,989
SEC Form 4
Lau Michele
Sell
EVP and Chief Legal Officer
MCK Feb 11, 2026
Avg Cost/Share
$933.39
Shares
303
Total Value
$282,817.17
Owned After
5,972
SEC Form 4
Rutledge Napoleon B JR
Sell
SVP, Controller & CAO
MCK Feb 6, 2026
Avg Cost/Share
$955.00
Shares
328
Total Value
$313,240.00
Owned After
0
SEC Form 4
Rodgers Thomas L
Sell
EVP, Chief Strategy & BDO
MCK Jan 5, 2026
Avg Cost/Share
$816.18
Shares
276
Total Value
$225,265.68
Owned After
2,268
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Smith LeAnn B | MCK | EVP & Chief HR Officer | Feb 17, 2026 | Sell | $945.00 | 190 | $179,550.00 | 2,989 | |
| Lau Michele | MCK | EVP and Chief Legal Officer | Feb 11, 2026 | Sell | $933.39 | 303 | $282,817.17 | 5,972 | |
| Rutledge Napoleon B JR | MCK | SVP, Controller & CAO | Feb 6, 2026 | Sell | $955.00 | 328 | $313,240.00 | 0 | |
| Rodgers Thomas L | MCK | EVP, Chief Strategy & BDO | Jan 5, 2026 | Sell | $816.18 | 276 | $225,265.68 | 2,268 |
Latest McKesson Corporation News
MCK Breaking Stock News: Dive into MCK Ticker-Specific Updates for Smart Investing
Zacks
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Barclays Adjusts Price Target on McKesson to $1,050 From $960, Maintains Overweight Rating
📈
AI Sentiment
Highly Positive
8/10
Barchart
Is Wall Street Bullish or Bearish on McKesson Stock?
📈
AI Sentiment
Highly Positive
10/10
Simply Wall St.
Is There An Opportunity With McKesson Corporation's (NYSE:MCK) 37% Undervaluation?
📈
AI Sentiment
Highly Positive
8/10
Compare MCK vs Leading Stocks
See how MCK stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MCK McKesson Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.